Detailed Study of the Liver Dialysis Equipment - Medical Devices Pipeline Assessment, 2017

Liver Dialysis Equipment - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Liver Dialysis Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Liver Dialysis Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Liver Dialysis Equipment - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Liver Dialysis Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Liver Dialysis Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Liver Dialysis Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Alliqua BioMedical Inc Excorp Medical Inc Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung eV Hep-Art Medical Devices BV University College London University of Minnesota Vital Therapies Inc Yaqrit Ltd

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Market Research on Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2017

Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Negative Pressure Wound Therapy (NPWT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Negative Pressure Wound Therapy (NPWT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Negative Pressure Wound Therapy (NPWT) - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Negative Pressure Wound Therapy (NPWT) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Negative Pressure Wound Therapy (NPWT) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Acelity L.P. Inc. Adept Medical Ltd Applied Tissue Technologies LLC Invacare Corporation LifeMedix, LLC Montana State University Otivio AS Shieldheart Medtech AB Smith & Nephew Plc University of Pisa Wake Forest Baptist Medical Center Worldwide Innovative Healthcare, Inc.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

New Research Explores on Hernia Repair Devices - Medical Devices Pipeline Assessment, 2017

Hernia Repair Devices - Medical Devices Pipeline Assessment, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Hernia Repair Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hernia Repair Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Complete report available @ Hernia Repair Devices - Medical Devices Pipeline Assessment, 2017

Scope

- Extensive coverage of the Hernia Repair Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hernia Repair Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hernia Repair Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

Acera Surgical, Inc. Advanced Medical Solutions Group plc ARISTE Medical ArTack Medical Ltd Atrium Medical Corp C. R. Bard Inc Cleveland Clinic Hospital Cytograft Tissue Engineering Inc DSM Biomedical BV Kerecis ehf LifeBond Ltd. Medprin Regenerative Medical Technologies Co Ltd MicroPort Scientific Corp Montana State University Nanovis Incorporated Soft Tissue Regeneration Inc TissueGen Inc University of Colorado

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Research Insights on Pancreatic Cancer Global Clinical Trials Review, H1, 2017

Pancreatic Cancer Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Pancreatic Cancer Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

F. Hoffmann-La Roche Ltd Novartis AG Pfizer Inc Sanofi AstraZeneca Plc Celgene Corp Eli Lilly and Company Merck & Co Inc AbbVie Inc Otsuka Holdings Co Ltd

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Market Review on Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017

Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Acute Spinal Cord Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Spinal Cord Injury. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

BioAxone BioSciences Inc AOSpine International Novartis AG Grupo Ferrer Internacional SA DP Clinical Inc Daiichi Sankyo Company Ltd CJ CheilJedang Corp Amgen Inc Allergan Plc Acorda Therapeutics Inc

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Recent Report on Acute Stress Disorder Global Clinical Trials Review, H1, 2017

Acute Stress Disorder Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Acute Stress Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Stress Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Acute Stress Disorder Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

Biologische Heilmittel Heel GmbH Daacro Chiltern International Ltd DSM Biologics Holdings Inc ChromaDex Corporation CeNeRx BioPharma, Inc. Baldwa Group Amino Up Chemical Co Ltd Allergan Plc Abbott Laboratories

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

In-Depth Study on Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2017

Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Acute Upper Respiratory Tract Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Upper Respiratory Tract Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Acute Upper Respiratory Tract Infections Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

Bluefish Pharmaceuticals AB Guangzhou Yipinhong Pharmaceutical Co Ltd NPF Materia Medica Holding Oasis Consumer Healthcare LLC Novartis AG Laboratoires Pierre Fabre SA ICON Plc Daewon Pharm Co Ltd ARMS Pharmaceutical LLC Ardeypharm GmbH

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

Detailed Research on Addison's Disease Global Clinical Trials Review, H1, 2017

Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Addison's Disease (Primary or Chronic Adrenal Insufficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Addison's Disease (Primary or Chronic Adrenal Insufficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

Shire Plc Amdipharm Mercury Company Ltd Amdipharm Mercury Debtco Ltd Charleston Area Medical Center Health System Inc E. Merck KG Ipsen SA Pfizer Inc

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###

New Report Explores on Adrenal Insufficiency Global Clinical Trials Review, H1, 2017

Adrenal Insufficiency Global Clinical Trials Review, H1, 2017 is a new market research publication announced by Reportstack. This report provides an overview of Adrenal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenal Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Complete report available @ Adrenal Insufficiency Global Clinical Trials Review, H1, 2017

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Companies Mentioned

Diurnal Group Plc Simbec Research Ltd Shire Plc Pfizer Inc E. Merck KG Charleston Area Medical Center Health System Inc Bristol Laboratories Group Ltd Axis Clinical Trials Amdipharm Mercury Debtco Ltd Amdipharm Mercury Company Ltd

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

ReportstackMarket Research

###